Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00478686
Status:
COMPLETED
Last Update Posted:
2017-05-08
First Post:
2007-05-23
Brief Title:
Association of Dihydropyrimidine Dehydrogenase DPYD Variants With Toxicity Related to Capecitabine
Sponsor:
Organization:
MD Anderson Cancer Center
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
5 to 75 milliliter mL sample of blood Alternatively DNA will be extracted from 10um slices of formalin-fixed paraffin-embedded tissue from previously collected tumor tissue from the time of the breast cancer diagnosis
Enrollment Count:
102
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Control |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 3253 |
Who Masked List: